Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04730544
Title Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC. (NIPISAFE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors GERCOR - Multidisciplinary Oncology Cooperative Group
Age Groups: adult | senior
Covered Countries FRA

Additional content available in CKB BOOST